UK Worst in Europe for Drug Prices, Says Eli Lilly
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
New research from the University of East Anglia finds omega-3 supplements don't improve cardiovascular outcomes in people with type 2 diabetes, challenging common health assumptions.
Groundbreaking research reveals how your daily cuppa could be a powerful weapon against type 2 diabetes. Discover the science behind tea's protective benefits.
Exclusive video evidence reveals the sophisticated, cramped, and perilous world of narco-submarines used by Colombian cartels to transport tonnes of cocaine across the ocean to global markets.
An NHS doctor highlights the subtle and often overlooked symptoms of type 2 diabetes, urging the public not to dismiss key changes in their body that could signal the condition.
The shocking true story of Dr. Robert Weitzel, the Utah paediatrician who prescribed millions of pills to teenagers in the 1970s, earning him the infamous nickname and sparking a national drug crisis.
Exclusive: British health authorities issue urgent alert about newly identified 'Type 5' diabetes, a deadly form striking young people with atypical symptoms and rapid progression.
New research from the UK finds eating whole apples, not just juice, significantly reduces the risk of developing type 2 diabetes. Discover the powerful benefits of this simple dietary change.
A grieving father's stark warning about a prescription drug's devastating effects as his son battles addiction. Exclusive investigation into the UK's growing dependency crisis.
Groundbreaking UK research reveals Hormone Replacement Therapy can significantly reduce the risk of developing type 2 diabetes in women, offering a potential new preventative treatment.
A school bus driver in the UK was apprehended for speeding and subsequently failed a roadside drug test while en route to collect children. The incident has sparked major concerns over pupil safety and vetting procedures.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
The Scottish Government stands accused of 'abject failure' as drug-related deaths soar to devastating new heights, with experts branding the crisis a national emergency that demands immediate action.
New research exposes a critical gap in the UK's health awareness, with Britons less likely to identify key diabetes symptoms compared to European neighbours. Experts warn this knowledge gap could lead to dangerous delays in diagnosis and treatment.
Exclusive: New NHS data reveals a shocking rise in diabetes diagnoses across Western countries, with the UK facing a growing healthcare emergency. Experts warn of unsustainable pressure on health services.
Shocking new report reveals the UK is falling behind other high-income countries in diagnosing diabetes, with nearly one million Brits living undiagnosed. Experts warn of a looming health catastrophe.
Groundbreaking research from Tufts University reveals that drugs like Ozempic and Wegovy are dramatically more effective for weight loss than traditional diet and exercise alone, potentially transforming the NHS's approach to the obesity epidemic.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
Donald Trump's radical new drug war strategy threatens to turn a metaphorical failure into a devastating reality, risking global stability and human rights.
An NHS administrator reveals how she lost four stone using a controversial cost-cutting method to obtain diabetes drug Mounjaro for weight loss, as doctors issue serious safety warnings.
Shocking new data reveals a stark postcode lottery for the diabetes and weight loss drug Mounjaro (tirzepatide) in England, with patients in some areas almost completely unable to access it on the NHS despite being eligible.
Families across England face a devastating postcode lottery as NHS refuses to fund essential glucose monitors for children with Type 1 diabetes, forcing desperate parents to crowdfund for basic medical care.
New research from Harvard suggests that eating breakfast before 7am significantly reduces the risk of developing type 2 diabetes, challenging conventional wisdom on meal timing and metabolic health.
A UK mum shares her astonishing journey of losing four stone during pregnancy after a gestational diabetes diagnosis. Her story is a powerful testament to health transformation.
Shocking investigation reveals Glasgow's grim status as Europe's drug death capital, with open-air drug use and discarded needles plaguing the city centre. Exclusive footage and expert insights expose a deepening public health emergency.
New figures reveal Scotland's drug death rate is more than double that of 2016 and triple the UK average, with Nicola Sturgeon's government facing fierce criticism over a public health emergency.
Exclusive analysis reveals Scotland's drug deaths crisis continues to spiral with opioid-related fatalities reaching unprecedented levels, as experts demand urgent policy reform.
Groundbreaking research from the University of Sheffield suggests a daily cup of a common 3p hot drink could be a powerful weapon against type 2 diabetes, potentially reducing risk by a staggering amount.
Exclusive: Cambridge scientists uncover compelling evidence linking common viral infections to the onset of diabetes, potentially revolutionising prevention and treatment approaches.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.